Jeremy Cooper
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Select Vaccines Limited
ABN 25 062 063 692
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the
purposes of section 205G of the Corporations Act.
Name of Director Jeremy Cooper
Date of last notice 4 July 2003
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a
director” should be disclosed in this part.
Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the
circumstances giving rise to
the relevant interest.
Director Related Entity
Date of change 7 August 2003
Direct Indirect
Shares - 197,500
No. of securities held prior
to change
Options (SLTO) - 250,000
Options (SLTOA) 750,000 67,500
Class Ordinary Shares & Options
Direct Indirect
Shares - -
Number acquired
Options (SLTO) - -
Options (SLTOA) - -
Direct Indirect
Shares - -
Number disposed
Options (SLTO) - (50,000)
Options (SLTOA) - -
Value/Consideration
Note: If consideration is non-cash,
provide details and estimated valuation
Sale on market @ $0.10
Direct Indirect
Shares - 197,500
No. of securities held after
change
Options (SLTO) - 200,000
Options (SLTOA) 750,000 67,500
Nature of change
Example: on-market trade, offmarket
trade, exercise of options,
issue of securities under dividend
reinvestment plan, participation in
buy-back
On market sale
Add to My Watchlist
What is My Watchlist?